Medicare Cost Rising on PSA Screenings, Men aged 75 and above Not Deriving Benefit
The Medicare fee-for-service program has spent whooping $447 million annually on PSA screenings. But then also, a research has unveiled that men aged 75 years and above are not being benefitted.
The study carried out by the Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center has raised concern of finding out the loop hole.
Study researchers have tried to know the reason as why the above mentioned age group is not able to derive benefit. In order to do so, they have got many other things.
While carrying out the study, it has been uncovered that the prostate cancer screening cost varies across places. Lead author Xiaomei Ma with team initiated a study on elderly men having Medicare benefit. The study took place in 2006 and the volunteers, who were free from prostate cancer, were followed for three years.
In the follow-up procedure, study researchers got to know about rise in Medicare spending as well as about variation in prostate cancer screening cost.
The change was not in the basic cost of testing but in the follow-up tests. "Our results suggest that the overall cost of prostate cancer screening may be heavily influenced by how urologists choose to respond to the result of a PSA test", said Ma.
New Zealand News
- What Does Phasing Out Cheques Tell Us About Finance in New Zealand?
- South Korean casino operator GKL closes third casino amid soaring cases of COVID-19
- Top Live Casinos in India and Pure Casino Signup Offer
- Independent MP Justin Field making efforts to prevent NSW from compensating Crown Resorts
- President-elect Biden’s Climate Plan to provide big boost to EVs and green power